Thomas DesRosier
CIK 1435744 · See Remarks · last filed 2026-07-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$482.3K
Companies
5
Total Filings
45
Lifetime Open-Market Net
-$1.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MCRB | See Remarks | 8,033 | $4.71 | $37.8K | -$92.5K | 25 | 2026-07-10 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | EVP, General Counsel | 55,000 | — | — | $0 | 3 | 2016-03-30 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | EVP, Chief Legal | 0 | — | — | $0 | 7 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | SVP, Chief Legal Officer & GC | 191 | — | — | $0 | 3 | 2013-10-02 |
| GENZ | Sr VP, General Counsel | 11,571 | $38.41 | $444.5K | -$937.1K | 7 | 2011-04-06 |
Recent Filings · Page 3 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-28 | MCRB | Exer (M) | +25,000 | $0 | EDGAR |
| 2019-01-29 | MCRB | Mixed | +9,529 | -$31.5K | EDGAR |
| 2018-01-30 | MCRB | Mixed | +6,525 | -$38.3K | EDGAR |
| 2017-01-27 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2016-06-02 | MCRB | Grant (A) | — | $0 | EDGAR |
| 2016-03-30 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +36,630 | -$92.4K | EDGAR |
| 2016-03-09 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-02-20 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-21 | CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Mixed | −8,446 | -$861.5K | EDGAR |
| 2015-01-05 | CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Other (J) | +148 | $8.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.